|
Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator …
MarketWatch (press release) Arcapta Neohaler is not indicated to treat asthma. It is also not indicated to treat acute deteriorations of COPD and should not be used as a rescue medication for acute symptoms. Arcapta Neohaler is the only once-daily, 24-hour long-acting … |
View full post on asthma – Google News